By Dr Matt Clifford and Dr Will Ormiston, Interventional Radiologists, Nedlands Benign prostatic hyperplasia (BPH) is the most common cause of lower urinary tract symptoms (LUTS) in older men, significantly impacting quality of life. While pharmacotherapy and surgical options such as transurethral resection of the prostate (TURP) remain mainstays of treatment, a growing cohort of patients are now turning toward minimally invasive, lower risk therapies that preserve sexual function and reduce recovery time. Prostate artery embolisation (PAE) has emerged as an endovascular alternative. With mounting high-level evidence, including multiple randomised controlled trials and long-term follow-up studies, PAE is now formally…
This content is restricted to site members. If you are an existing user, please log in. New users may register below.